Protonix Injection, Powder, For Solution
Product Images NDC 55154-4225

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 55154-4225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

0e813403 54ba 4523 9123 592cd3232ade 00

0e813403 54ba 4523 9123 592cd3232ade 00
PROTONIX® LV is an injection of 40mg pantoprazole sodium in 5 single-dose vials for intravenous use only. Each vial contains 40mg of pantoprazole sodium equivalent to 45.1mg of pantoprazole. The product contains 1mg of edetate disodium and should be protected from light. The recommended storage temperature is between 20°C and 25°C with excursions down to 15°C and up to 30°C. The product must not be used in children and must be kept out of their reach. The package is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. under license from Takeda GmbH in Konstanz, Germany. A detailed product insert is available for information about dosage, administration, precautions, and warnings.*
FDA Label Image

Chemical Structure (Protonix Iv 01)

Chemical Structure (Protonix Iv 01)
FDA Label Image

Protonix Iv 02

Protonix Iv 02
GBD riectaties is a medicine product that is distributed by Wyeth Pharmaceuticals, a subsidiary of Pfizer Inc, located in Philadelphia, PA 19101.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.